Table 3.

Percentage of performing additional intracavitary radiotherapy (ICRT)

Characteristics	Additional ICRT	p value
Treatment
Chemoradiotherapy	33% (19/58)	0.47
Radiation therapy – alone	24% (4/17)
FIGO Stage
I/II	28% (11/39)	0.63
III/IV	33% (12/36)
Hb
< 12	44% (14/32)	0.1
≥ 12	24% (8/33)
Age
< 60	30% (12/40)	0.89
≥ 60	31% (11/35)
Pathological type
Squamous cell carcinoma	29% (19/65)	0.67
Adenocarcinoma	50% (2/4)
Adenosquamous cell carcinoma	33% (2/6)